Clients

Arch Therapeutics, Inc.

Company Snapshot: Arch Therapeutics, Inc.

ARTH
Last Change Volume High Low

Company Overview

Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.

Client News

  1. May 30 2019 Arch Therapeutics to Provide Corporate Update at the 9th Annual LD Micro Invitational
  2. May 13 2019 Arch Therapeutics, Inc. $2.8 Million Registered Direct Offering
  3. Apr 24 2019 Arch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel Video
  4. Mar 11 2019 Arch Therapeutics to Provide Corporate Update at the 31st Annual ROTH Conference